These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3593220)

  • 1. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially.
    Lee CY; Rechler MM
    Endocrinology; 1995 Feb; 136(2):668-78. PubMed ID: 7530649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man.
    Hardouin S; Hossenlopp P; Segovia B; Seurin D; Portolan G; Lassarre C; Binoux M
    Eur J Biochem; 1987 Dec; 170(1-2):121-32. PubMed ID: 2961563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.
    Powell DR; Rosenfeld RG; Baker BK; Liu F; Hintz RL
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1186-92. PubMed ID: 3760118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt stimulation of serum insulin-like growth factor binding protein activity.
    Palka J; Peterkofsky B
    Anal Biochem; 1988 Dec; 175(2):442-9. PubMed ID: 2467583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum.
    Cornell HJ; Herington AC
    Int J Biochem; 1983; 15(4):553-8. PubMed ID: 6852354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial purification and characterization of somatomedin from sheep serum.
    Hossner KL; Davis SL; Powell C; Sasser RG
    Endocrinology; 1985 Apr; 116(4):1351-6. PubMed ID: 3971919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I binding proteins in serum from the domestic fowl.
    Armstrong DG; McKay CO; Morrell DJ; Goddard C
    J Endocrinol; 1989 Mar; 120(3):373-8. PubMed ID: 2466933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin-like growth factor II/mannose-6-phosphate receptor is present in monkey serum.
    Gelato MC; Kiess W; Lee L; Malozowski S; Rechler MM; Nissley P
    J Clin Endocrinol Metab; 1988 Oct; 67(4):669-75. PubMed ID: 2971079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The study of insulin-like growth factors in Tilapia, Oreochromus mossambicus.
    Drakenberg K; Sara VR; Lindahl KI; Kewish B
    Gen Comp Endocrinol; 1989 May; 74(2):173-80. PubMed ID: 2714623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, specificity, and regulation of the insulin-like growth factor-binding proteins in adult rat serum.
    Yang YW; Wang JF; Orlowski CC; Nissley SP; Rechler MM
    Endocrinology; 1989 Sep; 125(3):1540-55. PubMed ID: 2547590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor II/mannose-6-phosphate receptor is present in fetal and maternal sheep serum.
    Gelato MC; Rutherford C; Stark RI; Daniel SS
    Endocrinology; 1989 Jun; 124(6):2935-43. PubMed ID: 2542005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the protein which binds insulin-like growth factor in human serum.
    Rapp R; Deger A; Blum W; Koch R; Weber U
    Eur J Biochem; 1988 Mar; 172(2):421-5. PubMed ID: 2450744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic conversion of insulin-like growth factors to an acidic form(s).
    Kuffer AD; Herington AC
    Biochem J; 1984 Oct; 223(1):97-103. PubMed ID: 6388567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-binding protein from human plasma. Purification and characterization.
    Martin JL; Baxter RC
    J Biol Chem; 1986 Jul; 261(19):8754-60. PubMed ID: 3722172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.
    Daughaday WH; Kapadia M
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6778-82. PubMed ID: 2771956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.
    Lee CY; Rechler MM
    Endocrinology; 1995 Nov; 136(11):4982-9. PubMed ID: 7588232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of preparative reversed-phase high-performance liquid chromatography to the isolation of insulin-like growth factor II from human serum.
    Cornell HJ; Brady PH
    J Chromatogr; 1987 Oct; 421(1):61-9. PubMed ID: 3429576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.